Variant report

Variant	nsv827042
Chromosome Location	chr1:228344737-228347464
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr1:228314188..228315980-chr1:228346492..228348438,2	K562	blood:

Extended variants
information (count: 112 )
Associated
traits (count: 93 )

Variant overlapped rSNPs/rCNVs (count:112 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs567359235	chr1:228344739-228344740	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs574035639	chr1:228344819-228344820	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
3	rs536398285	chr1:228344831-228344832	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
4	rs539180577	chr1:228344834-228344835	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
5	rs556371473	chr1:228344865-228344866	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
6	rs111427073	chr1:228344880-228344881	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
7	rs576191602	chr1:228344882-228344883	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
8	rs188779706	chr1:228344966-228344967	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
9	rs151119099	chr1:228344969-228344970	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
10	rs572366103	chr1:228344977-228344978	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
11	rs541018245	chr1:228345010-228345011	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs141093786	chr1:228345013-228345014	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs574572877	chr1:228345028-228345029	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs140606139	chr1:228345065-228345066	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs201230346	chr1:228345149-228345150	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs543546801	chr1:228345198-228345199	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs559463555	chr1:228345216-228345217	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs563873751	chr1:228345238-228345239	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs149837848	chr1:228345248-228345249	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs552786140	chr1:228345285-228345286	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs559803779	chr1:228345303-228345304	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs528832817	chr1:228345325-228345326	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs547412690	chr1:228345334-228345335	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs376318575	chr1:228345351-228345352	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs567296544	chr1:228345370-228345371	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs536337713	chr1:228345378-228345379	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs549625102	chr1:228345392-228345393	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs569785905	chr1:228345393-228345394	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs577811454	chr1:228345402-228345403	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs138357152	chr1:228345510-228345511	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs149590094	chr1:228345515-228345516	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs75469429	chr1:228345567-228345568	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs376848686	chr1:228345580-228345581	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs267606847	chr1:228345602-228345603	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs139992251	chr1:228345606-228345607	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs146183345	chr1:228345634-228345635	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs371443995	chr1:228345639-228345640	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs149908950	chr1:228345700-228345701	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs373522338	chr1:228345710-228345711	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs74315312	chr1:228345727-228345728	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs12075149	chr1:228345729-228345730	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs148764840	chr1:228345744-228345745	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs202209462	chr1:228345750-228345751	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs372240320	chr1:228345759-228345760	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs375288744	chr1:228345761-228345762	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs147954793	chr1:228345762-228345763	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs368990340	chr1:228345770-228345771	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs574511063	chr1:228345777-228345778	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs543481065	chr1:228345832-228345833	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs563631405	chr1:228345877-228345878	Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:93)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Rett syndrome	21593744	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Liposarcoma	21253554	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	17603634	CNVD
Neuroblastoma	21899760	CNVD
Breast cancer	21858162	CNVD
Non-small cell lung cancer	21385341	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Testicular germ cell tumor	18059402	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Breast cancer	21509527	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	21177765	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Chordoma	18071362	CNVD
T-cell lymphomas	19863542	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hepatocellular carcinoma	18803288	CNVD
Urothelial tumor	18831757	CNVD
Lung cancer	18438408	CNVD
Medulloblastoma	16783165	CNVD
Basal cell lymphoma	17170743	CNVD
Mental retardation	19951919	CNVD
Non-syndromic sensorineural hearing loss	17873649	CNVD
Basal cell lymphoma	17053054	CNVD
Autism	14699429	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Fumarase deficiency	21572526	CNVD
Autism	17483303	CNVD
Kartagener syndrome	16639409	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	21549014	CNVD
Mental retardation	21549014	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	21138945	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Cancer	20164920	CNVD
Cancer	17060936	CNVD
Myelofibrosis	22110671	CNVD
abnormal development	18461090	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Lung adenocarcinoma	21935476	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:187 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:228332800-228349800	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
2	chr1:228333800-228350400	Weak transcription	Primary B cells from cord blood	blood
3	chr1:228336800-228350200	Weak transcription	Sigmoid Colon	Sigmoid Colon
4	chr1:228337800-228349800	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
5	chr1:228338000-228349200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
6	chr1:228338000-228349600	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
7	chr1:228338200-228344800	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
8	chr1:228338200-228344800	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
9	chr1:228338200-228352400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr1:228338400-228349200	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
11	chr1:228339000-228346000	Weak transcription	HMEC	breast
12	chr1:228339400-228345000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
13	chr1:228339400-228352600	Weak transcription	Brain Anterior Caudate	brain
14	chr1:228339600-228345600	Weak transcription	Right Atrium	heart
15	chr1:228339600-228349000	Weak transcription	NHLF	lung
16	chr1:228339800-228349400	Weak transcription	Brain Angular Gyrus	brain
17	chr1:228340000-228349200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
18	chr1:228340200-228345200	Weak transcription	Right Ventricle	heart
19	chr1:228340600-228349600	Weak transcription	Colon Smooth Muscle	Colon
20	chr1:228341800-228345400	Enhancers	Primary T helper cells PMA-I stimulated	--
21	chr1:228342200-228345200	Enhancers	Primary T helper naive cells fromperipheralblood	blood
22	chr1:228342600-228350000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
23	chr1:228342800-228345800	Enhancers	Lung	lung
24	chr1:228342800-228346400	Weak transcription	Stomach Smooth Muscle	stomach
25	chr1:228343000-228347200	Weak transcription	Brain Cingulate Gyrus	brain
26	chr1:228343200-228345600	Weak transcription	Placenta Amnion	Placenta Amnion
27	chr1:228343200-228349200	Weak transcription	K562	blood
28	chr1:228343400-228344800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr1:228343400-228344800	Weak transcription	Fetal Intestine Small	intestine
30	chr1:228343400-228347400	Weak transcription	NHEK	skin
31	chr1:228343400-228352400	Weak transcription	A549	lung
32	chr1:228343800-228344800	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
33	chr1:228343800-228345400	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
34	chr1:228343800-228345600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
35	chr1:228344000-228345000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
36	chr1:228344000-228345400	Flanking Active TSS	Primary hematopoietic stem cells	blood
37	chr1:228344000-228345400	Enhancers	Primary T helper cells fromperipheralblood	blood
38	chr1:228344000-228345400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
39	chr1:228344000-228346000	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
40	chr1:228344200-228344800	Flanking Active TSS	Primary T cells from cord blood	blood
41	chr1:228344200-228344800	Bivalent Enhancer	Fetal Stomach	stomach
42	chr1:228344200-228345200	Flanking Active TSS	Primary T killer naive cells fromperipheralblood	blood
43	chr1:228344200-228345200	Flanking Active TSS	Fetal Thymus	thymus
44	chr1:228344200-228345600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
45	chr1:228344200-228345600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
46	chr1:228344200-228345600	Weak transcription	Pancreas	Pancrea
47	chr1:228344200-228346400	Enhancers	Spleen	Spleen
48	chr1:228344200-228347200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
49	chr1:228344200-228348400	Weak transcription	Gastric	stomach
50	chr1:228344200-228348400	Weak transcription	Hela-S3	cervix

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links